These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 10361700

  • 1. Synthesis and biological evaluation of 1,2,3,4-tetrahydroisoquinoline derivatives as potent and selective M2 muscarinic receptor antagonists.
    Watanabe T, Kinoyama I, Takizawa K, Hirano S, Shibanuma T.
    Chem Pharm Bull (Tokyo); 1999 May; 47(5):672-7. PubMed ID: 10361700
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonists.
    Watanabe T, Kakefuda A, Tanaka A, Takizawa K, Hirano S, Shibata H, Yamagiwa Y, Yanagisawa I.
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):53-68. PubMed ID: 9468637
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of novel succinamide derivatives having the 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one skeleton as potent and selective M2 muscarinic receptor antagonists. I.
    Watanabe T, Kinoyama I, Kakefuda A, Okazaki T, Takizawa K, Hirano S, Shibata H, Yanagisawa I.
    Chem Pharm Bull (Tokyo); 1997 Jun; 45(6):996-1007. PubMed ID: 9214706
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of novel succinamide derivatives having a 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one skeleton as potent and selective M2 muscarinic receptor antagonists. II.
    Watanabe T, Kakefuda A, Kinoyama I, Takizawa K, Hirano S, Shibata H, Yanagisawa I.
    Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1458-69. PubMed ID: 9331998
    [Abstract] [Full Text] [Related]

  • 5. Synthesis of new cardioselective M2 muscarinic receptor antagonists.
    Mandelli GR, Maiorana S, Terni P, Lamperti G, Colibretti ML, Imbimbo BP.
    Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1611-22. PubMed ID: 11086886
    [Abstract] [Full Text] [Related]

  • 6. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML, Minarini A, Budriesi R, Cacciaguerra S, Chiarini A, Spampinato S, Tumiatti V, Melchiorre C.
    J Med Chem; 1998 Oct 08; 41(21):4150-60. PubMed ID: 9767650
    [Abstract] [Full Text] [Related]

  • 7. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M, Lazareno S, Pfaff O, Friebe T, Tastenoy M, Mutschler E, Lambrecht G.
    Br J Pharmacol; 1996 Dec 08; 119(7):1319-30. PubMed ID: 8968538
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.
    Wang Y, Chackalamannil S, Hu Z, Clader JW, Greenlee W, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, McQuade R, Lachowicz JE.
    Bioorg Med Chem Lett; 2000 Oct 16; 10(20):2247-50. PubMed ID: 11055330
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective muscarinic antagonists. I. Synthesis and antimuscarinic properties of 4-piperidyl benzhydrylcarbamate derivatives.
    Naito R, Takeuchi M, Morihira K, Hayakawa M, Ikeda K, Shibanuma T, Isomura Y.
    Chem Pharm Bull (Tokyo); 1998 Aug 16; 46(8):1274-85. PubMed ID: 9734315
    [Abstract] [Full Text] [Related]

  • 12. Selective muscarinic antagonists. II. Synthesis and antimuscarinic properties of biphenylylcarbamate derivatives.
    Naito R, Takeuchi M, Morihira K, Hayakawa M, Ikeda K, Shibanuma T, Isomura Y.
    Chem Pharm Bull (Tokyo); 1998 Aug 16; 46(8):1286-94. PubMed ID: 9734316
    [Abstract] [Full Text] [Related]

  • 13. Functional and binding studies with muscarinic M2-subtype selective antagonists.
    Lazareno S, Roberts FF.
    Br J Pharmacol; 1989 Sep 16; 98(1):309-17. PubMed ID: 2804551
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
    Naito R, Yonetoku Y, Okamoto Y, Toyoshima A, Ikeda K, Takeuchi M.
    J Med Chem; 2005 Oct 20; 48(21):6597-606. PubMed ID: 16220976
    [Abstract] [Full Text] [Related]

  • 15. Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder.
    Schneider T, Hein P, Michel-Reher MB, Michel MC.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul 20; 372(1):71-8. PubMed ID: 16059734
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.
    Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW.
    Bioorg Med Chem Lett; 2000 Oct 02; 10(19):2209-12. PubMed ID: 11012031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol.
    Varoli L, Angeli P, Burnelli S, Marucci G, Recanatini M.
    Bioorg Med Chem; 1999 Sep 02; 7(9):1837-44. PubMed ID: 10530931
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.